Can Prostate Cancer Really Respond to Immunotherapy?

被引：3
|
作者：
Kim, Won [1 ]
Fong, Lawrence [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 01期
关键词：
CELL LUNG-CANCER; ELM-PC; 5; UNTREATED MELANOMA; DOUBLE-BLIND; NIVOLUMAB; DOCETAXEL; IPILIMUMAB; TRIAL; CHEMOTHERAPY; MULTICENTER;
D O I：
10.1200/JCO.2016.70.4791
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / +
页数：3
相关论文
共 50 条
  • [41] Immunotherapy for lethal prostate cancer
    Rescigno, Pasquale
    de Bono, Johann S.
    NATURE REVIEWS UROLOGY, 2019, 16 (02) : 69 - 70
  • [42] Immunotherapy for prostate cancer.
    Rini B.I.
    Small E.J.
    Current Oncology Reports, 2001, 3 (5) : 418 - 423
  • [43] Immunotherapy in metastatic prostate cancer
    Slovin, Susan F.
    INDIAN JOURNAL OF UROLOGY, 2016, 32 (04) : 271 - 276
  • [44] Promising immunotherapy for prostate cancer
    Henegan, John C.
    Sonpavde, Guru
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (02) : 109 - 120
  • [45] Advances in immunotherapy for prostate cancer
    Markiewicz, MA
    Kast, WM
    ADVANCES IN CANCER RESEARCH, VOL 87, 2003, 87 : 159 - 194
  • [46] Immunotherapy for the treatment of prostate cancer
    Giuseppe Di Lorenzo
    Carlo Buonerba
    Philip W. Kantoff
    Nature Reviews Clinical Oncology, 2011, 8 : 551 - 561
  • [47] A Perspective of Immunotherapy for Prostate Cancer
    Silvestri, Ida
    Cattarino, Susanna
    Giantulli, Sabrina
    Nazzari, Cristina
    Collalti, Giulia
    Sciarra, Alessandro
    CANCERS, 2016, 8 (07)
  • [48] Immunotherapy for metastatic prostate cancer
    Drake, Charles G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (04) : 438 - 444
  • [49] Advances in prostate cancer immunotherapy
    Havranek, EG
    Whelan, MA
    Greenhalgh, R
    Dalgleish, AG
    Pandha, H
    SURGICAL ONCOLOGY-OXFORD, 2002, 11 (1-2): : 35 - 45
  • [50] IMMUNOTHERAPY A vaccine for prostate cancer?
    Flemming, Alexandra
    NATURE REVIEWS CANCER, 2011, 11 (08) : 540 - 540
12345